Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
Lebrikizumab en melfalan flufenamide in de sluis geplaatst
dec 2023 | Eczeem, MM